Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2025-08-15 00:00:00 ET · period of report 2025-08-13 · accession 0001830755-25-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-08-15 | 2025-08-13+ | ARWR | Hamilton James C | Chief Medical Off | S - Sale | $20.00 | -10.0K | 262.1K | -4% | -$200.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-08-13 | S | D | 611 | $20.00 | 271,511 | D | — | — | (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions. |
| 2 | Common | Common Stock | 2025-08-15 | S | D | 9,389 | $20.00 | 262,122 | D | — | — | (F2) Includes previously reported shares of common stock underlying Restricted Stock Units granted to the Reporting person, a portion of which are still subject to certain vesting conditions. |